In a study in the May issue of the Journal of Nuclear Medicine, researchers from the University of Michigan Medical Center concluded that SPECT/CT changed postsurgical staging in 21% of patients with thyroid cancer, modified the treatment approach in 36% of those with the disease, and helped avoid unnecessary radiation therapy in 20% of patients with no disease.